SECUADO® provided smooth onset, steady delivery, and low peak-to-trough ratios3
Asenapine pharmacokinetics at steady state is dose-proportional in the dose range of 3.8 mg/24 hours to 7.6 mg/24 hours following application of the patch.1 Steady-state plasma concentrations are achieved in about 72 hours after the first application of SECUADO.1
Avoid exposing SECUADO® to direct external heat sources during wear because both the rate and extent of absorption are increased.
You are now leaving the SECUADO® (asenapine) transdermal system website and moving to an external website independently operated and not managed by Noven